lead endocannabinoid research and offer the world the most efficacious drugs derived from cannabis. 

ROYAL CONCENTRTES is a biopharma company that manufactures and distributes poly-pharmaceutical drugs prepared from the cannabis Sativa plant.  The company is in the process of approving the drugs with FDA for immediate entry into the market.  There are currently three (3) drugs in development: drug “A” treats neurodegenerative diseases, drug “B” manages pain and drug “C” treats various types of cancer